EPAS1 and salivary gland cancer: We found that the pooled HR for MFS was 2.67 (95% CI 1.32–5.38, p = 0.0061), indicating that HIF2α expression is a negative prognostic factor for MFS in patients with prostate and salivary gland cancer (Figure 7).